share_log

美诺华(603538.SH)发上半年业绩,净利润1894.25万元,同比减少38.61%

Ningbo Menovo Pharmaceutical (603538.SH) released its first half-year performance, with a net income of 18.9425 million yuan, a decrease of 38.61% year-on-year.

Zhitong Finance ·  Aug 30 04:44

Ningbo Menovo Pharmaceutical (603538.SH) released the 2024 interim report, reporting a revenue of 6....

Zhixun Finance APP news, Ningbo Menovo Pharmaceutical (603538.SH) released the 2024 interim report, reporting a revenue of 0.608 billion yuan, a 4.40% year-on-year increase; net income attributable to shareholders of the listed company was 18.9425 million yuan, a 38.61% year-on-year decrease; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 19.6562 million yuan, a 23.64% year-on-year decrease; basic earnings per share was 0.09 yuan/share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment